ActR-I is a type I serine/threonine kinase receptor which has been shown to bind activin and bone morphogenetic proteins (BMPs). To study the function of ActR-I, we have generated novel monoclonal antibodies that speci®cally recognize the extracellular domain of mouse ActR-I. We examined the level of ActR-I protein during mouse development by immunohistochemistry. We found that in the embryonic body, ActR-I protein ®rst appears in a restricted part of the primitive streak region and is present throughout the length of notochord. Furthermore, ActR-I protein is expressed in the facial sensory organ primordia, including eye area, otic vesicle and olfactory placode, which all contain invaginating ectoderm. In addition, ActR-I is produced in pituitary primordium (Rathke's pouch), mammary buds and the epithelial layer of branchial arches. Interestingly, in the lens placodes and in early Rathke's pouch, ActR-I protein is transiently localized at the apical surface of the epithelial cells, indicating the presence of an apical-basal asymmetry in these cells. q
Results and discussion
The action of TGF-b family peptides is mediated by at least two distinct transmembrane serine/threonine kinases, classi®ed type I and type II receptors. The ligands act as adapters that bind and bring together these receptors. In the resulting complex, the type II receptors phosphorylate the type I receptors, leading to activation of the latter. The activated type I receptors are the signal transducers and responsible for the propagation of the signal to intracellular targets, including the recently identi®ed Smad family proteins (Massague Â, 1998) . ActR-I (ALK2) is a type I receptor for activins (Attisano et al., 1993; Ebner et al., 1993a; Carcamo et al., 1994) , which has also been shown to bind to TGF-b (Ebner et al., 1993a) , BMP2 and BMP7 (ten Dijke et al., 1994; Liu et al., 1995) as plausible ligands. Although the distribution of ActR-I transcripts has been examined by in situ hybridization in mice at the late organogenesis stage (E12.5; Verschueren et al., 1995) , the localization of the receptor proteins, which actually function in the signaling pathway and whose levels would not necessarily mirror the levels of their mRNAs, has never been established.
To clarify the spatiotemporal expression pattern of ActR-I at the protein level during embryonic development, we have generated novel monoclonal antibodies (mAbs) that recognize the extracellular domain of mouse ActR-I. The binding speci®city of the puri®ed antibodies was tested using denatured and undenatured antigens as shown in Fig. 1 . Both mAb 1C7 and 2A7 bound speci®cally to the 62-kDa ActR-I band on the Western blots, but not at all to ActR-IB (Fig. 1A , top and middle panels), while the presence of comparable levels of ActR-I and ActR-IB proteins was shown by staining with anti-Flag antibody (Fig. 1A, bottom panel) . Used in immunocytochemistry, both mAbs intensely stained cells transfected with the ActR-I vector (Fig. 1B) . By sharp contrast, the transfectants overproducing ActR-IB were not stained by either antibody, nor by control normal IgG. Essentially similar results were obtained from the cells either ®xed with methanol or with paraformaldehyde, revealing that each monoclonal antibody bound to its epitope in the ActR-I extracellular region under non-denaturing conditions. These results clearly indicated that mAb 1C7 and 2A7 speci®cally recognize ActR-I with little cross-reaction and hence are highly suitable for immunochemical applications. We analyzed the expression of ActR-I protein during early mouse development by using the mAb 2A7, which consistently yielded clearer results. Embryos at different stages were ®rst examined by whole-mount immunohistochemistry and subsequently by paraf®n-embedded sectioning of the specimens for closer inspection.
At E7.5, the extraembryonic layer was selectively stained by the antibody, indicating apparent ActR-I production (Figs. 2A and 4A) . During later stages (E7.5±E15.5), staining in the extraembryonic regions, including visceral yolk sac and amnion, were consistently observed. Recently, gene targeting and chimera studies have indicated that ActR-I in the extraembryonic cells is required for early gastrulation (Gu et al., 1999) . ActR-I protein was not yet detectable in the epiblast at E7.5 ( Figs. 2A and 4A ). In the embryonic body, ActR-I was initially detected at E8.0 and thereafter was detected with a characteristic expression pattern as follows. At E8.0, ActR-I staining showed its expression in the primitive streak and the prospective notochord region of the embryonic body, in addition to its broad distribution over the extraembryonic layer. The solid staining looked like a thin but discrete belt extending around the distal part of the embryonic egg cylinder along the antero-posterior direction (Fig. 3A) . The stained area extended caudally from the belt is widely branched (Fig. 3A) . The ®nding of the gene disruption study that initially formed primitive streak in the mutant embryos failed to elongate (Gu et al., 1999 ) is in agreement with the ActR-I production and its possible role in the primitive streak during normal development. Interestingly, at this stage, nodal expression has been reported around the adjacent node region (Zhou et al., 1993; Conlon et al., 1994; Collignon et al., 1996) . At the following stage, E8.5, ActR-I protein was clearly detected throughout most of the length of the notochord (Fig. 2B ), whereas the available data do not yet indicate the probable ligand for ActR-I in the notochord. Notably, bottle-shaped cells at the rostral extremity of the notochord (Fig. 3B , arrowhead) and the ®rst branchial arches (Figs. 2B and 3B) possessed ActR-I protein. ActR-I was also present in the closing gut continuous with the visceral endoderm (Fig. 2B ). During E9.0 and E9.5, the distribution of ActR-I protein became prominent in the olfactory placodes, the eye primordia, the otic vesicles, branchial arches and Rathke's pouch (the prospective anterior lobe of the pituitary gland), and it was preserved in the notochord (Fig. 2C,D) . In the developing eyes of E9.5 embryos, lens placode produced signi®cant levels of ActR-I (Fig. 2D ). In the thickening lens placode cells, ActR-I protein was principally accumulated on the apical surface side, which would be toward the amniotic uid (not shown). Similarly, ActR-I protein in Rathke's pouch, which is derived from the embryonic ectoderm at the roof of the primitive mouth cavity, was localized primarily on the apical surface of the epithelial cells surrounding the The right side view of an E8.5 embryo. ActR-I protein is detected in the notochord, the gut, branchial arches, amnion and visceral endoderm in a tissue-speci®c manner. (C) E9.0. ActR-I protein is present in the notochord, branchial arches, embryonic endoderm and extraembryonic endoderm. (D) E9.5. ActR-I protein is expressed in the lens placode, the olfactory placode, the otic vesicle and Rathke's pouch (future anterior lobe of the pituitary gland), all of which are ectodermal anlagen undergoing dynamic epithelial invagination movement. ActR-I staining persists in the notochord, the gut and branchial arches. (E) E10.5. ActR-I protein continues to be present in the notochord, branchial arches, oropharyngeal epithelium, Rathke's pouch and the lens vesicle. (F) E11.5. ActR-I protein is detected in the conjunctival sac and mammary gland primordia. ActR-I protein is evident in the notochord, oropharyngeal epithelium, tongue and Rathke's pouch, but no signal is detectable in the lens. Prior to staining, ®xed embryos older than E9.5 were parasagittally bisected to ensure suf®cient permeability to the reagents. Control embryos incubated with normal rat IgG were not signi®cantly stained. A, amnion; BA, branchial arch; E, eye; G, gut; MG, mammary gland; N, notochord; OP, olfactory placode; OV, otic vesicle; RP, Rathke's pouch. Each bar indicates 200 mm. lumen (Fig. 4B) . In the branchial arches and olfactory placodes, ActR-I protein was detected speci®cally in the surface epithelial cells but not in mesenchymal cells (Fig.  4D and not shown) . The staining in the notochord was still intense and almost uniform from the rostral extremity to the tail end (Figs. 2D and 3C,D) , although determination of the functional signi®cance of the persistent ActR-I protein in the differentiated notochord await future studies. At E10.5, ActR-I protein persisted in the total length of the notochord, in the oropharyngeal epithelium, the nasal region, the otic vesicles, branchial arches and Rathke's pouch as well as the eye region (Fig. 2E) . The invaginating lens vesicle main-tained ActR-I protein at signi®cant levels. ActR-I was also present in the overlying ectoderm, which gives rise to the cornea and conjunctiva, at E10.5 and remained visible along the furrow surrounding the corneal ectoderm, which consists of the epithelial cells at the bottom of the invaginating groove, at E11.5 (Fig. 2E,F) . Interestingly, ActR-I protein turned out to be detected distinctly on the mammary gland primordia, which were differentiated from the epidermal layer in the ventral trunk region (Figs. 2F and 4F) . Expression of ActR-I was observed in the epithelium of the oropharyngeal region, including the tongue, at E12.5, while ActR-I was reduced in the nasal cavity and in the ears. As late as E15.5, ActR-I protein persisted in the anterior lobe of the pituitary gland, which had developed from Rathke's pouch (Fig. 4C) , and in the epithelium of the oropharyngeal region, most obviously in the tongue surface (Fig. 4E) . At this stage, ActR-I was no longer detected in the mammary buds or in the notochord (not shown).
Our results have revealed ActR-I protein present in the overall notochord cells continuously from the gastrulation stage and during early development, although no previous report has noted detection of its RNA in the notochord.
Furthermore, we demonstrated that ActR-I is localized asymmetrically at the apical domain in the epithelial cells of Rathke's pouch and the lens placode, indicating a cellular polarity in these cells for introduction of responsive signals via the receptor. These results clearly show the superiority of our antibodies for the analysis of the protein level of ActR-I during morphogenesis, because the intracellular localization and accurate timing of the expression of the receptor protein, which could not be determined by in situ hybridization, have ®rst been revealed by the use of these antibodies.
This detailed analysis of the protein localization has indicated several new features of ActR-I expression. The present results will provide a valuable basis and tools for future studies of ActR-I signaling in development.
Experimental procedures

Cell culture
Sp2/0-Ag14 (Sp2) myeloma cells and Sp2-derived hybridoma cells were cultured in IDME. During the screening, the medium was supplemented with IL-6 (BriClone at 5%, BioResearch Ireland) for supporting the clonal growth.
DNA clones
The expression vector for ActR-I(ECR)-Ig was prepared by inserting a cDNA encoding the extracellular region (Met 1 -Glu 123 ) of mouse ActR-I in an expression vector for human Igg 1 fusion protein (Zettlemeissl et al., 1990) . The ActR-I cDNA fragment was obtained by PCR, in which the primers were synthesized based on the known sequence (Ebner et al., 1993b) and had an arti®cial XhoI site and BamHI site. Similarly, cDNAs for murine ActR-I and ActR-IB were obtained as XbaI-EcoRI fragments from E17 embryos (Ebner et al., 1993b; Verschueren et al., 1995) . An AvrII-BamHI fragment encoding the Flag-tag was attached to the cDNAs at the 3 H end, and the constructs were inserted between the XbaI and BamHI sites of the expression vector pactEF (Okazaki and Sagata, 1995) to obtain pactEF-ActR-I-Flag and pactEF-ActR-IB-Flag.
Rat immunization and hybridoma screening
For expression of ActR-I(ECR)-Ig fusion protein, 293T cells were transiently transfected by the calcium phosphate co-precipitation procedure. The medium was harvested several times, and the secreted fusion protein in the supernatant was puri®ed with a protein A column. Sprague± Dawley rats were immunized by four injections of 0.5 mg ActR-I(ECR)-Ig emulsi®ed with Freund's adjuvant, and the rat splenocytes were xenogenically fused with mouse Sp2 cells using standard procedures (Ware et al., 1984; He Ârion and De Coen, 1986) . Hybridoma supernatants were preincubated with human IgG (Cappel) to block antibodies against the Ig portion of the immunogen, and assayed by ELISA. Finally, two clones of hybridomas, which produced rat antibodies 1C7 and 2A7, were established after limiting dilution. The monoclonal antibodies were puri®ed from the culture supernatants and ascites using protein A.
Immunochemical procedures
Transfected 293T cells were ®xed in ice-cold 10% trichloroacetic acid, rinsed three times with 90% acetone and lyzed in SDS-sample buffer. Protein samples were boiled in the presence of 2% SDS without reducing reagent and subjected to Western blotting. For immunocytochemistry, transfected 293T cells were ®xed either in cold methanol or 4% paraformaldehyde/PBS and incubated in 2% skim milk. Monoclonal antibodies were used as primary antibodies, and antigens were visualized by using HRP-conjugated secondary antibody and chromogenic substrate (TrueBlue, Kirkegaard and Perry Lab).
Whole-mount immunohistochemistry was carried out according to Hogan et al. (1994) with minor modi®cations. Mouse (ICR) embryos were ®xed in a mixture of methanol and dimethylsulfoxide (4:1). On a rocking platform, embryos were treated with 5% H 2 O 2 to remove endogenous peroxidase activity, immersed in PBS containing 2% skim milk and 0.5% Triton X-100, and incubated with either mAb 2A7 (10 mg/ml) or control IgG. After several extensive washes, embryos were incubated with HRP-conjugated sheep anti-rat Ig (1 mg/ml). The chromogenic reaction was performed with diaminobenzidine (0.6 mg/ml) followed by addition of H 2 O 2 (0.03%). Embryos were post®xed in 4% paraformaldehyde and dehydrated in a methanol series. For photography, embryos were made transparent by immersion in a mixture of benzyl alcohol and benzyl benzoate (1:2). In the oropharynx at a later gestation stage, ActR-I protein is present in the surface epithelial cells of the tongue and in other oropharyngeal epithelium. (F) E11.5. ActR-I protein is expressed in mammary gland primordia in the ventral trunk region. ActR-I protein expression in the mammary buds is transitory, because the signals are evident at E11.5 but disappear by E12.5 (not shown). 1BA, ®rst branchial arch; 2BA, second branchial arch; M, mesoderm; MG, mammary gland primordium; NE, neural ectoderm; NT, neural tube; OPX, oropharynx; RP, Rathke's pouch; T, tongue; VE, visceral endoderm. All the panels show transverse sections at the same magni®cation as in (A), except (B); bars indicate 100 mm.
